Understanding RET in NSCLC

Y

Update on Stage 4/Recurrent Non-Squamous NSCLC: Efficacy Data of Selpercatinib in RET Fusion-Positive Patients

By Yasir Elamin FEATURING Mary Redman, Jhanelle Gray
299 views
September 30, 2020
Comments 0
Login to view comments. Click here to Login
07:26

UNC's Update on Targeted Therapy for Advanced NSCLC: Selpercatinib f…

UNC Lineberger Comprehensive Cancer Center

S. Patel

159 views
08:21

Optimal 1L Therapy for mNSCLC: Available Targeted Therapies and Phys…

Conor Steuer

725 views
05:47

Managing mNSCLC Patients With a Molecular Target: How Promising Are …

Penn Medicine 2020 Updates in Oncology

J. Bauml

140 views
15:34

Genomic Testing in Lung Cancer: How to Detect Biomarkers? What Are t…

Saeed Al Turki

547 views
08:51

Utilization of Targeted Therapy in NSCLC: Updates on RET & IC Activi…

Edgardo Santos​

421 views
13:53

Choosing Wisely in Precision Oncology: Genomic Medicine & Test Inter…

ecancer

S. Popat

373 views